Oncopeptides AB (publ), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, announces that the company has received a...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the first presentation of Phase 2 data and updated Phase 1 data from the MajesTEC-1...
